China ADR Privatizations: The Challenges of Getting the Best Deal
The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...
605 Views
Opening of E-commerce Channel to Change China's Drug Market
Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...
602 Views
China Resources Beverage IPO Lockup- Cornerstones Coming Out of Lockup Ahead of the Large PE Release
China Resources Beverage (2460 HK) raised around US$750m in its Hong Kong IPO in October 2024. The lockup on its cornerstone investors is set to...
537 Views
China Resources Beverage Pre-IPO - Peer Comparison - Middling
China Resources Beverage is looking to raise US$1bn in its upcoming Hong Kong IPO. We have looked at the company's past performance in our previous...
535 Views
Oneness Biotech (4743 TT): Marketing Progress of Fespixon in China Opens a New Revenue Stream
Oneness Biotech partners with CR Double Crane for exclusive commercialization of Fespixon in China, Hong Kong, and Macau. Fespixon is approved in...
488 Views